Compounds and compositions for delivering active agents

1. A compound selected from:

and salts thereof.

2. A pharmaceutical composition comprising:

(A) at least one biologically active agent; and

(B) a compound of claim 1 .

3. The pharmaceutical composition of claim 2 , wherein said biologically active agent is selected from the group consisting of

Amylin, Amylin Agonists, Adrenocorticotropin, Antigens, Antimicrobials, Antibiotics, Anti-Bacteria's, Anti-Fungal Agents, Anti-Migraine Agents, Calcitonin Gene-Related Protein Antagonists, Sumatriptan Succinate, Antivirals, Atrial Naturetic Factor, Bisphosphonates, Salmon Calcitonin, Eel Calcitonin, Porcine Calcitonin, Human Calcitonin, Cholecystokinin (CCK), CCK Agonists; Cromolyn Sodium, Cyclosporine, Desferrioxamine (DFO), Erythropoietin, Exedin, Exedin Agonists, Filgrastim, Follicle Stimulating Hormone, Glucagon-Like Peptide 1 (GLP-1), Glucagon, Glucagon-Like Peptide 2 (GLP-2); Glucocerebrosidase, Gonadotropin Releasing Hormone, Growth Hormone Releasing Factor; Growth Hormone Releasing Hormones, Growth Hormones, Human Growth Hormones (hGH), Recombinant Human Growth Hormones (rhGH), Bovine Growth Hormones, Porcine Growth Hormones; Heparin, Unfractionated Heparin, Heparinoids, Dermatans, Chondroitins, Low Molecular Weight Heparin, Very Low Molecular Weight Heparin, Ultra Low Molecular Weight Heparin, synthetic heparins, Porcine Insulin, Bovine Insulin, Human Insulin, Human Recombinant Insulin; Insulin-Like Growth Factor, IGF-1; Interferons, α Interferons, β Interferons, θ Interferons, γ Interferons; Interleukin-1; Interleukin-2; Interleukin-11; Interleukin-21; Leutinizing Hormone, Leutinizing Hormone Releasing Hormone, Leptin, Monoclonal Antibodies, TNF-alpha soluble receptors, Oxytocin, Parathyroid Hormone (PTH), PTH fragments, PTH 1-34, PTH 1-38, Peptide YY (PYY), PYY Agonists, Prostaglandins; Protease Inhibitors, Somatostatin, Thrombopoietin, Vancomycin, Vasopressin, Vitamins, Vaccines, and combinations thereof.

4. A compound selected from:

and salts thereof.

5. A pharmaceutical composition comprising:

(A) at least one biologically active agent; and

(B) a compound of claim 4 .

6. A pharmaceutical composition comprising:

(A) at least one biologically active agent; and

(B) a compound selected from:

and salts thereof, wherein

said biologically active agent is selected from the group consisting of Amylin, Amylin Agonists, Adrenocorticotropin, Antigens, Antimicrobials, Antibiotics, Anti-Bacterials, Anti-Fungal Agents, Anti-Migraine Agents, Calcitonin Gene-Related Protein Antagonists, Sumatriptan Succinate, Antivirals, Atrial Naturetic Factor, Bisphosphonates, Salmon Calcitonin, Eel Calcitonin, Porcine Calcitonin, Human Calcitonin, Cholecystokinin (CCK), CCK Agonists; Cromolyn Sodium, Cyclosporine, Desferrioxamine (DFO), Erythropoietin, Exedin, Exedin Agonists, Filgrastim, Follicle Stimulating Hormone, Glucagon-Like Peptide 1 (GLP-1), Glucagon, Glucagon-Like Peptide 2 (GLP-2); Glucocerebrosidase, Gonadotropin Releasing Hormone, Growth Hormone Releasing Factor; Growth Hormone Releasing Hormones, Growth Hormones, Human Growth Hormones (hGH), Recombinant Human Growth Hormones (rhGH), Bovine Growth Hormones, Porcine Growth Hormones; Heparin, Unfractionated Heparin, Heparinoids, Dermatans, Chondroitins, Low Molecular Weight Heparin, Very Low Molecular Weight Heparin, Ultra Low Molecular Weight Heparin, synthetic heparins, Porcine Insulin, Bovine Insulin, Human Insulin, Human Recombinant Insulin; Insulin-Like Growth Factor, IGF-1; Interferons, α Interferons, β Interferons, θ Interferons, γ Interferons; Interleukin-1; Interleukin-2; Interleukin-11; Interleukin-21; Leutinizing Hormone, Leutinizing Hormone Releasing Hormone, Leptin, Monoclonal Antibodies, TNF-alpha soluble receptors, Oxytocin, Parathyroid Hormone (PTH), PTH fragments, PTH 1-34, PTH 1-38, Peptide YY (PYY), PYY Agonists, Prostaglandins; Protease Inhibitors, Somatostatin, Thrombopoietin, Vancomycin, Vasopressin, Vitamins, Vaccines, and combinations thereof.

7. A compound selected from:

and salts thereof.

8. A pharmaceutical composition comprising:

(A) at least one biologically active agent; and

(B) a compound of claim 7 .

9. A pharmaceutical composition comprising:

(A) at least one biologically active agent; and

(B) a compound selected from

and salts thereof.

10. A compound selected from:

and salts thereof.

11. A pharmaceutical composition comprising:

(A) at least one biologically active agent; and

(B) a compound of claim 10 .

12. A compound selected from:

and salts thereof.

13. A pharmaceutical composition comprising:

(A) at least one biologically active agent; and

(B) a compound of claim 12 .

14. The pharmaceutical composition of claim 2 , wherein the biologically active agent is recombinant human growth hormone.

15. The pharmaceutical composition of claim 2 , wherein the biologically active agent is insulin.

16. The pharmaceutical composition of claim 2 , wherein the biologically active agent is heparin.

17. The pharmaceutical composition of claim 2 , wherein the biologically active agent is calcitonin.

18. The pharmaceutical composition of claim 2 , wherein the biologically active agent is interferon.

19. The pharmaceutical composition of claim 2 , wherein the biologically active agent is cromolyn sodium.

20. A compound according to claim 1 , selected from Compounds 3, 4, 6, 8, 11, 13, 14, 16, 18, 19, 20, 21, and salts thereof.

21. A pharmaceutical composition comprising (A) at least one biologically active agent and (B) a compound of claim 20 .

22. A compound according to claim 4 , selected from Compounds 23-27, 30-35, 38, 39, 41-49, 51-55, 57-59, 61-65, 68, 69, 71-78, 80-85, 87, 88, 90-96, 98-104, 106-108, 110, and salts thereof.

23. A pharmaceutical composition comprising (A) at least one biologically active agent and (B) a compound of claim 22 .

24. A compound selected from

and salts thereof.

25. A pharmaceutical composition comprising (A) at least one biologically active agent and (B) a compound of claim 24 .